We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • Topics
  • Dermatology
  • Cardiovascular
  • Diabetes
  • GI
  • HIV/AIDS
  • Quiz
  • Photoclinic
  • Image IQ
  • Special Report

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • Topics
  • Dermatology
  • Cardiovascular
  • Diabetes
  • GI
  • HIV/AIDS
  • Quiz
  • Photoclinic
  • Image IQ
  • Special Report

SUBSCRIBE: eNewsletter

Opioids & Medicare Part D: A Quiz on Questionable Prescribing

  • Grace Halsey
Apr 9, 2018
  • Pain
  • Opioids & Medicare Part D: A Quiz on Questionable Prescribing

  • Question #1: What percentage of opioids prescribed to Medicare Part D recipients were schedule II or III controlled substances?

  • Answer: C. 80% of prescribed opioids were DEA schedule II or III substances, which have the highest potentional for abuse. 

  • Question #2: In 2016, how much did Medicare Part D pay for Schedule II and III opioids? 

  • Answer: C. Spending by Medicare Part D increased by 165% in 2016 to $3.9 billion for Schedule II and III opioids. 

  • Question #3: Which opioids were most commonly prescribed in 2016 to Medicare Part D recipients? 

  • Answer: C. Tramadol. 

    Number of  prescriptions written in 2016 for schedule III opioids:
    Hydrocodone-acetaminophen (325 mg) combinations:

    • 5 mg: 11.3 million
    • 10 mg: 11.2 million
    • 7.5 mg: 5.7 million

    Oxycodone-acetaminophen (325 mg) combinations:

    • 5 mg: 5 million
  • Question #4: Which two states had the highest proportions of beneficiaries receive at least 1 opioid prescription? 

  • Answer: A. Alabama ranked first with 46% of beneficiaries receiving at least 1 opioid prescription and Mississippi trailed behind at 45%. 

    For the other states:

    • Arkansas: 44%
    • Oklahoma: 42%
    • Tennessee: 42%
    • Louisiana: 42%
  • Question #5: Research shows that the risk of opioid dependence increases substantially for patients who continuously receive opioids for how long?

  • Answer: B. 3 months. In 2016, 5 million beneficiaries received opioids for 3 months or more. Of those, 3.6 million received opioids for 6 months and around 610,000 received them for an entire year. 

  • Question #6: Approximately 500,000 beneficiaries received "high" amounts of opioids through Medicare Part D (excludes members being treated for cancer or receiving hospice care). What was the average daily MED given to these patients for at least 3 months? 

  • Anwer: C. A daily MED of 120 mg = 12 tablets of hydrocodone (10)/acetaminophen (325) or 16 tablets of oxycodone (5)/acetaminophen (325). These doses exceed the 90 mg daily MED level that CDC says should be avoided even in patients with chronic pain.

  • Question 7: True or false? The most commonly prescribed opioid for those beneficiaries identified as receiving high amounts was oxycodone 20 mg. 

  • Answer: B. False. Oxycodone 30 mg was the most commonly prescribed opioid for Medicare Part D recipients. 

  • Question #8: True or false? The CDC Guidelines for Prescribing Opioids for Chronic Pain identifies an average daily MED > 300 mg for 12 months, an "extreme amount"
    of opioid consumption. 

  • Answer: B. False. A daily MED of > 240 mg for an entire year qualifies as an extreme amount. 

    Per the CDC, average daily MED:

    • Level to avoid: ≥90 mg
    • High amount: >120 mg for 3 months
    • Extreme amount: >240 mg for 12 months
  • Question #9: Which of the above identifies a patient who is "doctor shopping" as defined by CMS?

  • Answer: C. A patient is considered "doctor shopping" if they have received an average daily MED over 120 mg for 3 months, had 4 or more prescribers, and used 4 or more pharmacies. 

  • Question #10: One Medicare Part D beneficiary received opioid prescriptions from 42 different prescribers and filled them at 37 different pharmacies in one year. During one month, as a result of prescriptions from one prescriber, the beneficiary received how many pills of oxycodone, hydromorphone, and morphine combined?

  • Answer: A. The beneficiary received prescriptions for a total of 2,330 opioid pills from a single provider in one month. 

In its efforts to police fraud, abuse, and misuse of opioids, the Office of the Inspector General (OIG), a division of the US Department of Health & Human Services, has focused on prescriptions for these extremely high-profile drugs obtained under Medicare Part D, the drug benefit for Medicare recipients. OIG issued a data brief in July 2017 titled Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing.

The 10 questions in the slides above are based on the report.  Some of the questions may not challenge what you know, but we think you’ll be surprised by the answers to others. Good luck!

 

For more information, check out the full report: Office of Inspector General, US Dept of Health & Human Services. Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing. Washington, DC: US Dept of Health and Human Services. 2017. HHS OIG Data Brief OEI-02-17-00250

Related Articles

  • 9 New Drugs for Primary Care: Q1 2018
  • Benzodiazepines and Opioids: A Quiz on the Dangerous Combination
  • Low Back Pain: A Short Quiz
  • Medication Overuse Headache: A Short Test
  • 7 Things About Acupuncture You May Not Know

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Asthma
Atrial Fibrillation
Respiratory Diseases
Headache and Migraine
Hepatitis C
There is currently no available content. Please check back soon.
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.